Suicide in Europe & Central Asia

This page presents suicide mortality data for countries in Europe & Central Asia, using age-standardized death rates per 100,000 population from the Institute for Health Metrics and Evaluation (IHME). Regional analysis reveals significant variation in disease burden between countries, reflecting differences in healthcare infrastructure, socioeconomic conditions, environmental risk factors, and public health policy implementation across Europe & Central Asia.

Suicide — intentional self-inflicted death — claims over 700,000 lives globally each year, making it a leading cause of death among young adults aged 15-29 in many countries. The aetiology is multifactorial: psychiatric illness (particularly major depression, bipolar disorder, and schizophrenia), substance use disorders, chronic pain, social isolation, economic hardship, and access to lethal means all contribute to risk. Men die by suicide at roughly twice the rate of women globally, though women attempt suicide more frequently — a phenomenon termed the gender paradox of suicidal behaviour. Geographical variation is stark: age-standardised suicide rates in high-income countries of Eastern Europe and East Asia significantly exceed those in Latin America and parts of Africa, though underreporting in low-income settings complicates comparisons. Pesticide self-poisoning accounts for an estimated 20% of global suicides, predominantly in rural agricultural communities across South and Southeast Asia. COVID-19 amplified risk factors through social isolation, economic disruption, and disrupted mental health services, though its aggregate impact on suicide rates has varied across countries. Europe and Central Asia benefit from relatively strong health systems and high physician density, but face ageing populations, rising non-communicable disease burdens, and persistent East-West health outcome gradients. In Europe & Central Asia, suicide mortality is near global averages, though the region exhibits a marked gradient between Western European countries with low rates and Central Asian nations facing higher burdens.

Evidence-based suicide prevention encompasses restriction of access to means (pesticide bans, firearm regulations, bridge barriers), gatekeeper training for primary care providers and community members, school-based programmes for adolescents, crisis helplines, and follow-up contact after suicide attempts. National suicide prevention strategies, recommended by the WHO, provide coordinated frameworks that integrate mental health services, surveillance, and public awareness campaigns. Media guidelines on responsible reporting of suicide are also essential to prevent contagion effects.

The mortality estimates presented on this page are derived from the Global Burden of Disease (GBD) study, produced by the Institute for Health Metrics and Evaluation (IHME). The GBD synthesizes data from vital registration systems, verbal autopsies, cancer registries, and surveillance networks across more than 200 countries and territories. Death rates are expressed per 100,000 population and are age-standardized, which adjusts for differences in age structure between populations so that comparisons across countries and over time reflect genuine differences in mortality risk rather than demographic composition.

The dataset typically covers the period from 1990 to 2023, although availability varies by country and cause. When interpreting the figures for suicide in Europe & Central Asia, note that higher age-standardized rates indicate a greater mortality burden independent of whether a country's population is older or younger. Trends over time reveal whether public health interventions, economic development, and health system improvements have reduced or increased the toll of this condition in the region.

Disease-specific death rates measure the number of deaths directly attributed to suicide per 100,000 people, after accounting for age structure. These rates capture both the prevalence of the condition and the likelihood of a fatal outcome once affected. In Europe & Central Asia, variation across countries may reflect differences in disease prevalence, access to treatment, diagnostic capacity, and the presence of comorbidities. Examining trends alongside health expenditure and intervention coverage helps identify where policy action has been most effective.

Suicide Worldwide All Causes in Europe & Central Asia Compare Countries Trends Suicide in East Asia & Pacific Suicide in Latin America & Caribbean Suicide in Middle East, North Africa, Afghanistan & Pakistan Suicide in North America